Someone else's clock has started running against them: the company is being paid to solve a problem that is already cost
The model's full reasoning — Q1 2017 call → NOWe need to answer YES or NO based on the transcript. The question: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS THEY DO NOT HAVE WHAT THIS COMPANY PROVIDES, and that this accumulating loss on the other side is ALREADY VISIBLE in how those parties are behaving toward the company today? We need to find if management describes a "running meter" on the counterparty's side, and that they are already acting like it. Also that this dynamic is generating business meaningful relative to company size and contribution still ahead. Throughout the call, Tom Joyce and Dan Comas describe many businesses. We need to see if any description fits. The typical Danaher businesses sell products that provide benefits. But the question is about a specific dynamic where waiting is expensive for the counterparty, and they are already showing urgency. Look for phrases like "customers are pressing for earlier delivery", "accepting worse terms", "committing sooner", "each period without costs them more". Also "meaningful relative to current size". In the transcript, there are many examples. But we need to find one coherent situation. For instance, Cepheid: they have tests that deliver results faster. But is there a running meter? The flu/RSV test delivers in 20 minutes vs slower. That saves time but is that a loss? Possibly for patients. But not described as accumulating loss for customers. Also the company is growing due to acquisitions. What about Pall? They help biopharma improve efficiency. Not a running meter. What about the AVT acquisition? No. What about Hach CM130 for dialysis? It tests chlorine levels frequently to prevent high chlorine events. That could be a safety issue, but not described as a running meter. What about the dental? No. Look at the question: "the counterparty's clock is already running: waiting is not neutral for them, it is expensive." Management must describe that. There is a section about SCIEX with pharma demand due to tightened regulations around generic drug production. That is a future rule? Actually it's already in force. But is the counterparty losing something? They need testing to comply, but management says "those are generating greater demand for testing." That's not a running meter, it's just demand.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
SYM · Q3 2022 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...YES The transcript shows management describing customers' ongoing pain from labor shortages and broken supply chains that prevent them from handling demand, with customers actively clamoring for faster deployments and wanting the system as quickly as possible.
CRL · Q2 2022 → YESThe question is whether management describes that their counterparties are already losing something real and ongoing — money, output, access, standing, time, or an opportunity — for as long as they do...
GTES · Q4 2021 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...